Clinical Trial

Amblyopia Treatment for Children Aged 8 to 12 Years

Recruiting
View on ClinicalTrials.gov →
Summary
This study is being done to assess the effect of at-home amblyopia treatment with Curesight™ for children aged 8 to 12 years. Curesight™ allows you to stream any videos on a computer screen at home but the amblyopic eye will see the entire screen clearly while part of the image will be blurred for the other eye. There is already a pivotal clinical trial showing that this treatment is effective for young children and Curesight™ has been cleared for use as an amblyopia treatment by the FDA for children as young as 4 years.
Trial Details
NCT Number NCT07281742
Lead Sponsor Retina Foundation of the Southwest
Conditions Amblyopia
Enrollment 30 participants
Start Date 2025-01-07
Primary Completion 2027-12-31 (estimated)
Study Completion 2028-06-30 (estimated)
Updated on ClinicalTrials.gov 2025-12-15